A Randomized Trial to Determine the Role of Valganciclovir for Asymptomatic Cytomegalovirus Infected Hearing Impaired Infants (ValEAR Trial)

Project: Research project

Project Details

StatusActive
Effective start/end date7/6/176/30/22

Funding

  • University of Utah (10041913-021 (1U01DC014706-01A1))
  • National Institutes of Health (10041913-021 (1U01DC014706-01A1))